| Michael Jon Spalding, MD | |
|
345 23rd Ave N, Suite 212, Nashville, TN 37203-1513 | |
| (615) 327-2055 | |
| (615) 329-4005 |
| Full Name | Michael Jon Spalding |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 345 23rd Ave N, Nashville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164488136 | NPI | - | NPPES |
| 3858975 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 7673 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Jon Spalding, MD 345 23rd Ave N, Suite 212, Nashville, TN 37203-1513 Ph: (615) 327-2055 | Michael Jon Spalding, MD 345 23rd Ave N, Suite 212, Nashville, TN 37203-1513 Ph: (615) 327-2055 |
News Archive
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall responses to future infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
For the past 18 months, while I was undergoing intensive physical therapy and many neurological tests after a complicated head injury, my friends would point to a silver lining: "Now you'll be able to write about your own bills." After all, I'd spent the past decade as a journalist covering the often-bankrupting cost of U.S. medical care.
› Verified 3 days ago
Ruchika Talwar, Urology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Kenya Lana Kimber, LPN Urology Medicare: Not Enrolled in Medicare Practice Location: 1310 24th Ave S, Nashville, TN 37212 Phone: 615-327-4751 | |
Robert B Barnett, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2801 Charlotte Ave, Nashville, TN 37209 Phone: 615-250-9200 Fax: 615-250-9251 | |
Ryan S Hsi, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Alberic Rogman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2801 Charlotte Ave, Nashville, TN 37209 Phone: 615-250-9200 Fax: 615-250-9251 | |
Raoul S Concepcion, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 28 White Bridge Rd, Suite 200, Nashville, TN 37205 Phone: 615-290-0622 | |
Douglas Milam, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 |